摘要
背景:人类脐带间充质干细胞(hUC-MSC)是治疗视网膜变性(RD)的潜在候选物。 目的:进一步研究hUC-MSCs对视网膜变性的生物学和治疗效果。 方法:采用单细胞克隆方法分离hUC-MSC1和hUC-MSC2两种hUC-MSC亚群,比较RCS大鼠RD模型的治疗作用。 结果:尽管这两个亚群都符合hUC-MSCs的基本要求,但它们在形态学,增殖率,分化能力,表型和基因表达方面显着不同。此外,只有较小的成纤维细胞样快速生长的子集hUC-MSC1表现出更强的集落形成潜力以及成脂和成骨分化能力。将两种亚型分别移植入RCS大鼠的视网膜下腔后,两种亚型均存活,但只有hUC-MSC1表达RPE细胞标记物蛋白激酶和RPE65。更重要的是,hUC-MSC1对视网膜功能具有更强的挽救作用,如ERG检查时b波振幅较高,视网膜核层较厚,凋亡的感光细胞减少。当两种亚型都用白细胞介素-6治疗时,模拟细胞移植到具有退化视网膜的眼中的炎症环境时,与hUC-MSC2相比,hUC-MSC1表达更高水平的营养因子。 结论:此处的数据除了证明hUC-MSCs的异质性外,证实hUC-MSC1的更强的治疗效果归因于其更强的抗凋亡作用,营养因子的旁分泌和潜在的RPE细胞分化能力。因此,应该使用子集hUC-MSC1而不是其他子集或未分组的hUC-MSC来有效治疗RD。
关键词: 人脐带间充质干细胞,视网膜变性,干细胞亚群,抗凋亡作用,细胞分化,旁分泌
Current Molecular Medicine
Title:Human Umbilical Cord Mesenchymal Stem Cells: Subpopulations and Their Difference in Cell Biology and Effects on Retinal Degeneration in RCS Rats
Volume: 17 Issue: 6
关键词: 人脐带间充质干细胞,视网膜变性,干细胞亚群,抗凋亡作用,细胞分化,旁分泌
摘要: Background: Human umbilical cord mesenchymal stem cells (hUC-MSCs) are potential candidates for treating retinal degeneration (RD).
Objective: To further study the biology and therapeutic effects of the hUC-MSCs on retinal degeneration.
Methods: Two hUC-MSC subpopulations, termed hUC-MSC1 and hUC-MSC2, were isolated by single-cell cloning method and their therapeutic functions were compared in RCS rat, a RD model.
Results: Although both subsets satisfied the basic requirements for hUC-MSCs, they were significantly different in morphology, proliferation rate, differentiation capacity, phenotype and gene expression. Furthermore, only the smaller, fibroblast-like, faster growing subset hUC-MSC1 displayed stronger colony forming potential as well as adipogenic and osteogenic differentiation capacities. When the two subsets were respectively transplanted into the subretinal spaces of RCS rats, both subsets survived, but only hUC-MSC1 expressed RPE cell markers Bestrophin and RPE65. More importantly, hUC-MSC1 showed stronger rescue effect on the retinal function as indicated by the higher b-wave amplitude on ERG examination, thicker retinal nuclear layer, and decreased apoptotic photoreceptors. When both subsets were treated with interleukin-6, mimicking the inflammatory environment when the cells were transplanted into the eyes with degenerated retina, hUC-MSC1 expressed much higher levels of trophic factors in comparison with hUC-MSC2.
Conclusion: The data here, in addition to prove the heterogeneity of hUC-MSCs, confirmed that the stronger therapeutic effects of hUC-MSC1 were attributed to its stronger anti-apoptotic effect, paracrine of trophic factors and potential RPE cell differentiation capacity. Thus, the subset hUC-MSC1, not the other subset or the ungrouped hUC-MSCs should be used for effective treatment of RD.
Export Options
About this article
Cite this article as:
Human Umbilical Cord Mesenchymal Stem Cells: Subpopulations and Their Difference in Cell Biology and Effects on Retinal Degeneration in RCS Rats, Current Molecular Medicine 2017; 17 (6) . https://dx.doi.org/10.2174/1566524018666171205140806
DOI https://dx.doi.org/10.2174/1566524018666171205140806 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The History and Rationale for Monoclonal Antibodies in the Treatment of Hematologic Malignancy
Current Pharmaceutical Biotechnology Microglial Integrity is Maintained by Erythropoietin Through Integration of Akt and Its Substrates of lycogen Synthase Kinase-3β, β-Catenin, and Nuclear Factor-κB
Current Neurovascular Research TGF-beta Signaling in Cancer Treatment
Current Pharmaceutical Design Genetic and Modifying Factors that Determine the Risk of Brain Tumors
Central Nervous System Agents in Medicinal Chemistry Meet Our Associate Editor
Current Molecular Medicine Regulatory Roles of Amino Acids in Immune Response
Current Rheumatology Reviews From Physiome to Pathome: A Systems Biology Model of Major Depressive Disorder and the Psycho-Immune-Neuroendocrine Network
Current Psychiatry Reviews Cardiovascular Adverse Effects of Anti-Inflammatory Drugs
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry High Density DNA Microarrays: Algorithms and Biomedical Applications
Current Medicinal Chemistry New Steroidal Anti-Inflammatory Antedrugs: 21-Thioalkylether Derivatives of Methyl 16-Prednisolone Carboxylates
Medicinal Chemistry p-Cymene Modulate Oxidative Stress and Inflammation in Murine Macrophages: Potential Implication in Atherosclerosis
Cardiovascular & Hematological Agents in Medicinal Chemistry From Brain Ischemia-Reperfusion Injury to Possible Sporadic Alzheimers Disease
Current Neurovascular Research Recent Advances in Synthesis of PAR Ligands as Therapeutic Strategy for Inflammatory Diseases
Mini-Reviews in Medicinal Chemistry Development of Colon Specific Microspheres of Flurbiprofen for Inflammatory Bowel Disease
Current Drug Delivery Can Microbicides Turn the Tide Against HIV?
Current Pharmaceutical Design Targeted Drug Delivery to Cancer Stem Cells through Nanotechnological Approaches
Current Stem Cell Research & Therapy Nano Technological Approaches for Anti-tumour Therapy: Opportunities and Challenges
Nanoscience & Nanotechnology-Asia 3D-QSAR Studies on a Series of Inhibitors Docked into a New Homology Model of the DNA-PK Receptor
Current Pharmaceutical Design Recent Advances Using Phosphodiesterase 4 (PDE4) Inhibitors to Treat Inflammatory Disorders: Animal and Clinical Studies
Current Drug Therapy Molecular Recognition and Drug-Lead Identification: What Can Molecular Simulations Tell Us?
Current Medicinal Chemistry